CIK 0001124105
- Accelerated filer
- Smaller reporting company
GYRE THERAPEUTICS, INC.
Sign in to watch- Ticker
- GYRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 562020050
- Phone
- +1 858-284-0115
- Business address
- 12730 HIGH BLUFF DRIVE, SUITE 250, SAN DIEGO, CA, 92130
- Former names
- CATALYST BIOSCIENCES, INC., TARGACEPT INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-03-08 | Flynn James E 10% owner | Sale | −1,194 | $30.00 | $36K | 1,121,345 |
| 2018-03-08 | Flynn James E 10% owner | Sale | −8,123 | $29.03 | $236K | 1,113,222 |
| 2018-03-07 | Flynn James E 10% owner | Sale | −7,252 | $30.00 | $218K | 814,013 |
| 2018-03-07 | Flynn James E 10% owner | Sale | −2,748 | $30.00 | $82K | 308,526 |
| 2018-03-07 | Flynn James E 10% owner | Sale | −10,000 | $30.00 | $300K | 1,122,539 |
| 2018-03-06 | Flynn James E 10% owner | Sale | −9,544 | $29.94 | $286K | 849,763 |
| 2018-03-06 | Flynn James E 10% owner | Sale | −3,617 | $29.94 | $108K | 322,076 |
| 2018-03-06 | Flynn James E 10% owner | Sale | −28,498 | $31.18 | $889K | 821,265 |
| 2018-03-06 | Flynn James E 10% owner | Sale | −10,802 | $31.18 | $337K | 311,274 |
| 2018-03-06 | Flynn James E 10% owner | Sale | −13,161 | $29.94 | $394K | 1,171,839 |
| 2018-03-06 | Flynn James E 10% owner | Sale | −39,300 | $31.18 | $1.2M | 1,132,539 |
| 2018-02-20 | Richard John P Director | Other disposition · Redeemable Convertible Note | −0 | |||
| 2018-02-20 | HILL STEPHEN A Director | Other disposition · Redeemable Convertible Note | −0 | |||
| 2018-02-20 | HILL STEPHEN A Director | Other disposition · Redeemable Convertible Note | −21,600 | 0 | ||
| 2018-02-20 | DESOUZA ERROL B Director | Other disposition · Redeemable Convertible Note | −0 | |||
| 2018-02-20 | DESOUZA ERROL B Director | Other disposition · Redeemable Convertible Note | −4,679 | 0 | ||
| 2018-01-16 | SELICK HAROLD E Director | Returned to the company · Stock Option (Right to Buy) | −197 | 0 | ||
| 2018-01-16 | SELICK HAROLD E Director | Grant or award · Stock Option (Right to Buy) | +197 | 197 | ||
| 2018-01-16 | SELICK HAROLD E Director | Returned to the company · Stock Option (Right to Buy) | −550 | 0 | ||
| 2018-01-16 | SELICK HAROLD E Director | Grant or award · Stock Option (Right to Buy) | +550 | 550 |
Page 21 of 24 · 471 trades